Debate concerning the safety of performing mastopexy concurrently with breast augmentation still exists with concerns of breast tissue neurovascular compromise and overall high complications rates. We describe a single stage procedure using a "Tailor-Tack" technique that consistently achieves an aesthetically pleasing breast while preserving tissue viability.
METHODS:
This is a retrospective chart review of all consecutive breast augmentations performed concurrently with mastopexy by the senior authors (M.M. and O.T.), from 2006 to 2017 using the current "Tailor-Tack" technique. We report patient demographics, breast implant placement, implant type, shape, and size, duration of follow-up, and complications. Complications reviewed include recurrent breast ptosis, poor shape of the nipple areolar complex, hypertrophic scarring, implant rupture, capsular contracture, nipple tissue loss, breast skin loss, decreased nipple sensation, implant infections or extrusion, reoperation, and scar revisions. In brief, the key principles of the technique included first placing the breast implant in the submuscular space, then performing tailor tacking of the skin in a modified Wise pattern to approximate the skin resection for the mastopexy. The patient was then placed in the sitting position and final adjustments were made.
RESULTS:
Fifty-six patients underwent augmentation with the "Tailor-Tack" mastopexy. The average age of the studied patients was 41.2 years. The average followup time period was 2.1 years (+/-8.9 months). Fifty-four patients (96.4%) had implants placed through a periareolar incision, two patients (3.6%) had implants placed through infra-mammary incisions. All implants were placed in a dual plane. Fifty-two patients (92.9%) received silicone implants and four patients (7.1%) received saline implants. Patient preference determined implant choice. All implants except five were textured. Average implant size was 277 ml (range 120-800).
Ten patients had complications (17.9%). Complications included hypertrophic scarring in 5 (8.9%) patients, 4 (7.1%) poor NAC shape, 3 (5.4%) implant ruptures, 3 (5.4%) capsular contracture, and 2 (3.6%) with recurrent ptosis. There was no reported nipple tissue loss, breast skin loss, decreased nipple sensation, or implant infections or extrusion. Six patients (10.7%) required return trips to the operating room for revisions and one patient (1.8%) had a nipple areolar complex scar revised in the office yielding a 12.5% surgical revision rate.
CONCLUSION:
Mastopexy can safely be performed concurrently with breast augmentation. In our elevenyear review, there were no catastrophic complications such as skin loss, nipple loss, implant extrusion, or infection. The complications that occurred were common complications known to occur with mastopexy alone and/or breast augmentation alone and occurred at rates comparable to or less than the national averages for those procedures when they are performed independently. The paramount principle for the success of this technique is to adjust breast volume initially and then perform an intra-operatively planned skin resection to fit the new breast volume. 
Amount of Blood Drained after

GOALS/PURPOSE:
The use of tubular drains in silicone gel breast augmentation remains a source of debate up to the risk of hematoma and capsular contracture as opposed to the risk of infection and the patient's intolerance. The objective of the study was to determine the amount of blood drained after pre-pectoral breast implants.
METHODS/TECHNIQUE:
We retrospectively analyzed a cohort of 30 females under 45 years old, submitted to a first aesthetic breast augmentation by pre-pectoral silicone smooth gel implants as solo surgery during 2011 and 2012. Patients with any disease and/or intake of any medication compromising coagulation or bleeding were excluded from this study. All of them were operated by the same surgeon with 20 years' experience in sub-pectoral technique, during 2011 and 2012. The patients were operated with general intravenously anesthesia and local infiltration with lidocaine and vasoconstrictors. The surgeries were performed by means of an inframammary incision. It was used a 4,8-mm bilateral tubular suctioning drain system until 72 hours post-surgery. The implants used were silicone round moderate projection type, with smooth envelope, gel filled with a constant brand. The amount of blood was collected and noted every 24 hours by the same method, with a 20-cc syringe. Patients were followed with a maximum of six years and a minimum of three years. All patients were submitted to magnetic resonance after three years of implantation.
RESULTS/COMPLICATIONS:
The mean age of the patients was 27 years (18-44). There were no complications during the procedure. The total amount of blood drained was from 86 cc to 355 cc, (normal distribution, average 187 cc); 56% of the total amount drained after 24 hours, 27% after 48 hours and 17 % after 72 hours. There was no hematoma, seroma, infection and capsular contracture. The patients didn't present bruising in the breast region. The resonance magnetic exams were considered normal for all the patients. One presented a small amount of liquid around the implant, one side after four years.
CONCLUSION:
It is important to observe the unexpected large amount of blood collected even the patient presented no risk factors and submitted to a procedure with careful hemostasis and aseptic technique. The absence of late seromas, hematomas or dense capsule formation, even in this small number of participants suggest the necessity of drainage for breast implants. It's important to emphasize the silicone characteristics as an inhibitor of clot formation that may result in a long-time presence of no coagulated blood around the implant. In the 1980's, we observed the presence of fibrin and uncoagulated blood around tissue expanders in the removal surgery step, 3 to 6 months after introduction and It was the first opportunity to understand the behavior of the presence blood around silicone. Based on our results, we emphasize the importance to perform more prospective studies regarding drainage after breast augmentation with silicone implants. 1-6 We present our clinical experience in breast masculinization using and ultrasound liposuction (VASER©).
Gynecomastia
METHODS AND MATERIALS:
Male breast topography was done by dividing each breast into 5 different zones (according to the breast relation to the surrounding muscles), in addition to a special zone of lipo-filling to augment the breast superiorly. The evaluation was performed 6 months after surgery to determine the degree of satisfaction and presence of complications.
RESULTS:
Thirty subjects were included in the analysis of this study with mean age of presentation 34.2 (5.5) years with a range from 27 to 49 years old. Twenty-five patients (83%) had grade II gynecomastia, three patients (10%) were grade III and two patients (7%) were grade IV gynecomastia (according to Rorhrich et al classification system). The mean BMI was 33.1 (2.1) Kg/m 2 with a range from 27 to 38. Eighteen (60%) of patient had chest lipo-augmentation, twelve (40%) only had liposculpture without fat injection. Ten (33%) cases had glandular disc excision. Mean volume of Fat injected was 104 (7.2) cc (range; 100-200 cc).
Among the 30 patients, total complications were seven (23.4%). Major complications were 3 (10%) and minor complications were 4 (13.4%)
CONCLUSION:
The new defined zones of the breast acts as a good guide to the surgeons when addressing a case of Gynecomastia. Liposuction and pectoral lipofilling using
